Abstract
Protein-ligand docking is an in silico tool used to screen potential drug compounds for their ability to bind to a given protein receptor within a drug-discovery campaign. Experimental drug screening is expensive and time consuming, and it is desirable to carry out large scale docking calculations in a high-Throughput manner to narrow the experimental search space. Few of the existing computational docking tools were designed with high performance computing in mind. Therefore, optimizations to maximize use of high-performance computational resources available at leadership-class computing facilities enables these facilities to be leveraged for drug discovery. Here we present the porting, optimization, and validation of the AutoDock-GPU program for the Summit supercomputer, and its application to initial compound screening efforts to target proteins of the SARS-CoV-2 virus responsible for the current COVID-19 pandemic.
Original language | English |
---|---|
Title of host publication | Proceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020 |
Publisher | Association for Computing Machinery, Inc |
ISBN (Electronic) | 9781450379649 |
DOIs | |
State | Published - Sep 21 2020 |
Event | 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020 - Virtual, Online, United States Duration: Sep 21 2020 → Sep 24 2020 |
Publication series
Name | Proceedings of the 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020 |
---|
Conference
Conference | 11th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics, BCB 2020 |
---|---|
Country/Territory | United States |
City | Virtual, Online |
Period | 09/21/20 → 09/24/20 |
Funding
This research was sponsored by the Laboratory Directed Research and Development Program at Oak Ridge National Laboratory (ORNL), which is managed by UT-Battelle, LLC, for the U.S. Department of Energy (DOE) under Contract No. DE-AC05-00OR22725, and used resources of the Oak Ridge Leadership Computing Facility, which is a DOE Office of Science User Facility supported under Contract DE-AC05-00OR22725. Development of the AutoDock-GPU was supported by the National Institutes of Health (GM069832). We thank Jonathan Lefman and Geetika Gupta (NVIDIA) for essential coordination and communication support.
Keywords
- Drug discovery
- GPU acceleration
- high-performance computing
- protein-ligand docking